Nuevolution Sitemap Nuevolution
 
September 20, 2011
Nuevolution Announces Collaboration in Drug Discovery with Boehringer Ingelheim
 
 
November 2, 2009
Nuevolution Announces Lead Discovery Collaboration in the Field of Epigenetic Disorders.
 
 

November 2, 2009

Nuevolution Announces Receipt of Milestone Payment from Merck & Co., Inc.



Chemetics
® - A Quantum Leap for Small Molecule Lead Discovery

Nuevolution A/S is a company dedicated to revolutionize fragment and HTS based lead discovery by applying its proprietary Chemetics® technologies enabling unprecedented synthesis and screening power for rapid and cost-efficient identification of drug leads.

Chemetics® represents the ultimate “convergent” drug discovery technology – a unique, patent protected fusion of proven wet chemistry and molecular biology methods producing an unrivaled capacity for synthesis and screening of millions to billions of drug-like molecules in a single test tube.


Discover ChemeticsDiscover Nuevolution
Home Sitemap Nuevolution info@nuevolution.com